BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26849445)

  • 21. Screening for Glucose-6-Phosphate Dehydrogenase Deficiency Using Three Detection Methods: A Cross-Sectional Survey in Southwestern Uganda.
    Roh ME; Oyet C; Orikiriza P; Wade M; Mwanga-Amumpaire J; Boum Y; Kiwanuka GN; Parikh S
    Am J Trop Med Hyg; 2016 Nov; 95(5):1094-1099. PubMed ID: 27672207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of detection of glucose-6-phosphate dehydrogenase deficiency using fluorescent spot test, enzyme assay and molecular method for prediction of severe neonatal hyperbilirubinaemia.
    Wang FL; Boo NY; Ainoon O; Wong MK
    Singapore Med J; 2009 Jan; 50(1):62-7. PubMed ID: 19224086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ethiopia: absence of common African and Mediterranean allelic variants in a nationwide study.
    Assefa A; Ali A; Deressa W; Tsegaye W; Abebe G; Sime H; Kebede A; Jima D; Kassa M; Abreha T; Teka H; Solomon H; Malone J; Shi YP; Zhou Z; Reithinger R; Hwang J
    Malar J; 2018 Oct; 17(1):388. PubMed ID: 30367627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and hematological indicators of G6PD deficiency in malaria-infected patients.
    Kotepui M; Uthaisar K; PhunPhuech B; Phiwklam N
    Infect Dis Poverty; 2016 Apr; 5():36. PubMed ID: 27109515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of quantitative point-of-care test for measurement of glucose-6-phosphate dehydrogenase enzyme activity in Malaysia.
    Zailani MAH; Raja Sabudin RZA; Abdul Jalil D; Ithnin A; Ayub NA; Alauddin H; Jalil N; Md Fauzi A; Cheah FC; Lim LS; Safian N; Yusuf MM; Othman A
    Malays J Pathol; 2023 Apr; 45(1):31-41. PubMed ID: 37119244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Field evaluation of a novel semi-quantitative point-of-care diagnostic for G6PD deficiency in Indonesia.
    Sadhewa A; Panggalo LV; Nanine I; Price RN; Thriemer K; Satyagraha AW; Ley B
    PLoS One; 2024; 19(4):e0301506. PubMed ID: 38687748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methods for the field evaluation of quantitative G6PD diagnostics: a review.
    Ley B; Bancone G; von Seidlein L; Thriemer K; Richards JS; Domingo GJ; Price RN
    Malar J; 2017 Sep; 16(1):361. PubMed ID: 28893237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modification to reporting of qualitative fluorescent spot test results improves detection of glucose-6-phosphate dehydrogenase (G6PD)-deficient heterozygote female newborns.
    Nadarajan V; Shanmugam H; Sthaneshwar P; Jayaranee S; Sultan KS; Ang C; Arumugam S
    Int J Lab Hematol; 2011 Oct; 33(5):463-70. PubMed ID: 21501392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Field evaluation of quantitative point of care diagnostics to measure glucose-6-phosphate dehydrogenase activity.
    Alam MS; Kibria MG; Jahan N; Thriemer K; Hossain MS; Douglas NM; Phru CS; Khan WA; Price RN; Ley B
    PLoS One; 2018; 13(11):e0206331. PubMed ID: 30388146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Point-of-care G6PD diagnostics for Plasmodium vivax malaria is a clinical and public health urgency.
    Baird JK
    BMC Med; 2015 Dec; 13():296. PubMed ID: 26652887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance Comparison Between Conventional Fluorescent Spot Test and Quantitative Assay in Detecting G6PD Deficiency in Neonates.
    Halim SA; Bahar R; Abdullah WZ; Zon EM; Yusoff SM
    Oman Med J; 2023 Jul; 38(4):e524. PubMed ID: 37724319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using the fluorescence spot test for neonatal screening of G6PD deficiency.
    Jiang J; Ma X; Song C; Lin B; Cao W; Wu S; Hsiao KJ
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():140-2. PubMed ID: 15906719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and risk factors for asymptomatic malaria and genotyping of glucose 6-phosphate (G6PD) deficiencies in a vivax-predominant setting, Lao PDR: implications for sub-national elimination goals.
    Lover AA; Dantzer E; Hongvanthong B; Chindavongsa K; Welty S; Reza T; Khim N; Menard D; Bennett A
    Malar J; 2018 Jun; 17(1):218. PubMed ID: 29859089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in southeast Iran: implications for malaria elimination.
    Tabatabaei SM; Salimi Khorashad A; Sakeni M; Raeisi A; Metanat Z
    J Infect Dev Ctries; 2015 Mar; 9(3):289-97. PubMed ID: 25771467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of G6PD deficiency in selected populations from two previously high malaria endemic areas of Sri Lanka.
    Gunawardena S; Kapilananda GM; Samarakoon D; Maddevithana S; Wijesundera S; Goonaratne LV; Karunaweera ND
    PLoS One; 2017; 12(2):e0171208. PubMed ID: 28152025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid epidemiologic assessment of glucose-6-phosphate dehydrogenase deficiency in malaria-endemic areas in Southeast Asia using a novel diagnostic kit.
    Jalloh A; Tantular IS; Pusarawati S; Kawilarang AP; Kerong H; Lin K; Ferreira MU; Matsuoka H; Arai M; Kita K; Kawamoto F
    Trop Med Int Health; 2004 May; 9(5):615-23. PubMed ID: 15117307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. G6PD Deficiency and Hemoglobinopathies: Molecular Epidemiological Characteristics and Healthy Effects on Malaria Endemic Bioko Island, Equatorial Guinea.
    Lin M; Yang LY; Xie DD; Chen JT; Nguba SM; Ehapo CS; Zhan XF; Eyi JU; Matesa RA; Obono MM; Yang H; Yang HT; Cheng JD
    PLoS One; 2015; 10(4):e0123991. PubMed ID: 25915902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucose-6-phosphate dehydrogenase deficiency neonatal screening: preliminary evidence that a high percentage of partially deficient female neonates are missed during routine screening.
    Reclos GJ; Hatzidakis CJ; Schulpis KH
    J Med Screen; 2000; 7(1):46-51. PubMed ID: 10807147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency in the neonatal period.
    Keihanian F; Basirjafari S; Darbandi B; Saeidinia A; Jafroodi M; Sharafi R; Shakiba M
    Int J Lab Hematol; 2017 Jun; 39(3):251-260. PubMed ID: 28258653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucose-6-phosphate dehydrogenase deficient variants are associated with reduced susceptibility to malaria in the Brazilian Amazon.
    Santana MS; Monteiro WM; Siqueira AM; Costa MF; Sampaio V; Lacerda MV; Alecrim MG
    Trans R Soc Trop Med Hyg; 2013 May; 107(5):301-6. PubMed ID: 23479361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.